Cargando…
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals
INTRODUCTION: Tenofovir disoproxil fumarate (TDF) has been associated with greater incidences of bone complications, which might be modified by some concomitantly administered antiretrovirals, possibly by their effect on tenofovir concentrations. We compared bone adverse outcomes among treatment-naï...
Autores principales: | LaFleur, Joanne, Bress, Adam P., Myers, Joel, Rosenblatt, Lisa, Crook, Jacob, Knippenberg, Kristin, Bedimo, Roger, Tebas, Pablo, Nyman, Heather, Esker, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986678/ https://www.ncbi.nlm.nih.gov/pubmed/29492905 http://dx.doi.org/10.1007/s40121-018-0194-1 |
Ejemplares similares
-
Health Care Costs in a Cohort of HIV-Infected U.S. Veterans Receiving Regimens Containing Tenofovir Disoproxil Fumarate/Emtricitabine
por: Nelson, Richard E., et al.
Publicado: (2018) -
Cardiovascular outcomes among HIV-infected veterans receiving atazanavir
por: LaFleur, Joanne, et al.
Publicado: (2017) -
High rates of early treatment discontinuation in hepatitis C-infected US veterans
por: LaFleur, Joanne, et al.
Publicado: (2014) -
Predicting poor adherence to antiretroviral therapy among treatment-naïve veterans infected with human immunodeficiency virus
por: Cheng, Yan, et al.
Publicado: (2018) -
The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health
por: Bedimo, Roger J., et al.
Publicado: (2014)